Pharmafile Logo

Navigating patients step by step on their clinical trial journey

For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in extra financial costs for sponsors and potentially placing the future of the trial in jeopardy.However, sites don’t always have the time and resources available to commit to ongoing and consistent patient engagement. In our upcoming webinar, we will discuss common challenges participants and sites face when it comes to engagement and how our new ‘Navigator’ service is helping to change the game.Hear how our new patient-centric service benefits patients, sites and sponsors by:Ensuring patients get the support they need for the best clinical trial experience possibleDecreasing the risk of early trial termination by improving the retention of participants until the very end of a studyReducing the burden on sites by performing a second layer of prescreening, allowing sites to focus on the scienceSpeakersChair – John Pinching, Editor, PharmaTimesKari Reilly – Patient Recruitment Manager, Innovative TrialsKristin Faber – VP of Clinical Trial Patient Recruitment, Spectrum ScienceAdel Sepulveda – Navigator, Innovative TrialsGwen Barger – Site Manager, CCT ResearchReferencesAlexander W. The uphill path to successful clinical trials: keeping patients enrolled. P T. 2013;38(4):225-227. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684189/


This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients

Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.

Kate Shaw reflects on Innovative Trials' first US office openings

On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening

Innovative Trials on the latest ABPI report

Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report

Innovative Trials featuring in a Clinical Trials Arena article

Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.

Overcoming Patient Recruitment Challenges in Rare Disease Trials

Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials

Innovative Trials and Pfizer invite you to attend the live webinar

Innovative Trials opens first US office

We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

Accelerating patient recruitment post-COVID-19

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Innovative Trials opens first US office

The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina